Literature DB >> 1173539

Comparison of in vitro potency of corticosteroids with ability to raise intraocular pressure.

H L Cantrill, P F Palmberg, H A Zink, S R Waltman, S M Podos, B Becker.   

Abstract

Mesh：

Substances：

Year:  1975        PMID： 1173539     DOI： 10.1016/0002-9394(75)90687-x

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN： 0002-9394            Impact factor:   5.258


× No keyword cloud information.
  20 in total

Review 1.  Ocular allergy treatments.

Authors:  L Bielory
Journal:  Clin Rev Allergy Immunol       Date:  2001-04       Impact factor: 8.667

2.  [Preoperative therapy switch before glaucoma filtration surgery : Influence of the systemic antiglaucomatous and local antiphlogistic therapy on the intraocular pressure].

Authors:  I Oberacher-Velten; F Zeman; F Lehmann; T Barth; P Peters; H Helbig; R Greslechner
Journal:  Ophthalmologe       Date:  2017-07       Impact factor: 1.059

3.  Steroid-induced glaucoma: A. Persistent elevation of intraocular pressure B. Histopathological aspects.

Authors:  G L Spaeth; M M Rodrigues; S Weinreb
Journal:  Trans Am Ophthalmol Soc       Date:  1977

4.  Effects of topical corticosteroid administration on intraocular pressure in normal and glaucomatous cats.

Authors:  Allyson A Gosling; Julie A Kiland; Lauren E Rutkowski; Adam Hoefs; Norman Matthew Ellinwood; Gillian J McLellan
Journal:  Vet Ophthalmol       Date:  2016-02-15       Impact factor: 1.644

Review 5.  Loteprednol etabonate ophthalmic gel 0.5%: a review of its use in post-operative inflammation and pain following ocular surgery.

Authors:  Katherine A Lyseng-Williamson
Journal:  Drugs       Date:  2013-06       Impact factor: 9.546

Review 6.  Corticosteroids in ophthalmology: drug delivery innovations, pharmacology, clinical applications, and future perspectives.

Authors:  Sherif A Gaballa; Uday B Kompella; Omar Elgarhy; Ali M Alqahtani; Barbara Pierscionek; Raid G Alany; Hamdy Abdelkader
Journal:  Drug Deliv Transl Res       Date:  2021-06       Impact factor: 4.617

Review 7.  Loteprednol etabonate ophthalmic suspension 0.5 %: efficacy and safety for postoperative anti-inflammatory use.

Authors:  Michael Amon; Massimo Busin
Journal:  Int Ophthalmol       Date:  2012-06-16       Impact factor: 2.031

8.  Glaucoma associated with the management of rhegmatogenous retinal detachment.

Authors:  George Mangouritsas; Spyridon Mourtzoukos; Dimitra M Portaliou; Vassilios I Georgopoulos; Anastasia Dimopoulou; Elias Feretis
Journal:  Clin Ophthalmol       Date:  2013-04-15

9.  The variant N363S of glucocorticoid receptor in steroid-induced ocular hypertension in Hungarian patients treated with photorefractive keratectomy.

Authors:  Viktória Szabó; Gábor Borgulya; Tamás Filkorn; Judit Majnik; Ilona Bányász; Zoltán Zsolt Nagy
Journal:  Mol Vis       Date:  2007-04-27       Impact factor: 2.367

10.  Loteprednol etabonate gel 0.5% for postoperative pain and inflammation after cataract surgery: results of a multicenter trial.

Authors:  Raymond Fong; Martin Leitritz; Raphaele Siou-Mermet; Tara Erb
Journal:  Clin Ophthalmol       Date:  2012-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.